Open Internet by MindsNet

Doxorubicin-induced cardiotoxicity in cancer chemotherapy

Doxorubicin-induced cardiotoxicity is a critical adverse event in clinical cancer chemotherapy, representing a significant limitation to treatment efficacy and patient safety. This condition can lead to severe cardiac damage, impacting the quality of life and survival of cancer patients. The challenge lies in mitigating this cardiotoxicity without compromising the therapeutic effectiveness of doxorubicin.

Science, Biology, Molecular Biology